<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0005" orientation="portrait" position="float">
 <label>Table 5.</label>
 <caption>
  <p>Results of ADME/
   <italic>T</italic>-test of the standard drugs.
  </p>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
  </colgroup>
  <thead>
   <tr>
    <th colspan="9" align="left">
     <bold>
      <underline>Absorption</underline>
     </bold>
    </th>
   </tr>
   <tr>
    <th align="left">
     <bold>Properties</bold>
    </th>
    <th align="center">Darunavir </th>
    <th align="center">Dexamethasone </th>
    <th align="center">Enalapril </th>
    <th align="center">Favipiravir </th>
    <th align="center">Losartan </th>
    <th align="center">Nelfinavir </th>
    <th align="center">Olmesartan </th>
    <th align="center">Remdesivir </th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td rowspan="2">Caco-2 Permeability (Optimal: higher than −5.15 Log unit or −4.70 or −4.80) </td>
    <td align="center">Not optimal </td>
    <td align="center">Optimal </td>
    <td align="center">Not optimal </td>
    <td align="center">Optimal </td>
    <td align="center">Optimal </td>
    <td align="center">Not optimal </td>
    <td align="center">Not optimal </td>
    <td align="center">Not optimal </td>
   </tr>
   <tr>
    <td align="center">–5.83 cm/s </td>
    <td align="center">–4.867 cm/s </td>
    <td align="center">–5.473 cm/s </td>
    <td align="center">–4.466 cm/s </td>
    <td align="center">–5.116 cm/s </td>
    <td align="center">–5.254 cm/s </td>
    <td align="center">–5.43 cm/s </td>
    <td align="center">–6.145 cm/s </td>
   </tr>
   <tr>
    <td rowspan="2">Human Intestinal Absorption (HIA) ≥30%: HIA+; &lt;30%: HIA– </td>
    <td align="center">– </td>
    <td align="center">++</td>
    <td align="center">+</td>
    <td align="center">+</td>
    <td align="center">++</td>
    <td align="center">– </td>
    <td align="center">+</td>
    <td align="center">– </td>
   </tr>
   <tr>
    <td align="center">(0.426) </td>
    <td align="center">(0.729) </td>
    <td align="center">(0.653) </td>
    <td align="center">(0.542) </td>
    <td align="center">(0.718) </td>
    <td align="center">(0.3) </td>
    <td align="center">(0.583) </td>
    <td align="center">(0.301) </td>
   </tr>
   <tr>
    <td rowspan="2">P-glycoprotein substrate </td>
    <td align="center">– </td>
    <td align="center">+</td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">+</td>
    <td align="center">+</td>
    <td align="center">––– </td>
   </tr>
   <tr>
    <td align="center">(0.495) </td>
    <td align="center">(0.5) </td>
    <td align="center">(0.179) </td>
    <td align="center">(0.011) </td>
    <td align="center">(0.716) </td>
    <td align="center">(0.686) </td>
    <td align="center">(0.511) </td>
    <td align="center">(0.142) </td>
   </tr>
   <tr>
    <td rowspan="2">P-glycoprotein inhibitor </td>
    <td align="center">++</td>
    <td align="center">– </td>
    <td align="center">+++</td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">++</td>
    <td align="center">+</td>
    <td align="center">++</td>
   </tr>
   <tr>
    <td align="center">(0.858) </td>
    <td align="center">(0.376) </td>
    <td align="center">(0.954) </td>
    <td align="center">(0.042) </td>
    <td align="center">(0.831) </td>
    <td align="center">(0.842) </td>
    <td align="center">(0.665) </td>
    <td align="center">(0.863) </td>
   </tr>
   <tr>
    <td align="left">Bioavailability score</td>
    <td align="center">0.55 </td>
    <td align="center">0.55 </td>
    <td align="center">0.55 </td>
    <td align="center">0.55 </td>
    <td align="center">0.56 </td>
    <td align="center">0.55 </td>
    <td align="center">0.56 </td>
    <td align="center">0.17 </td>
   </tr>
   <tr>
    <td align="left">GI absorption </td>
    <td align="center">Low </td>
    <td align="center">High </td>
    <td align="center">High </td>
    <td align="center">High </td>
    <td align="center">High </td>
    <td align="center">Low </td>
    <td align="center">High </td>
    <td align="center">Low </td>
   </tr>
   <tr>
    <td colspan="9">
     <underline>
      <bold>Distribution</bold>
     </underline>
    </td>
   </tr>
   <tr>
    <td align="left">
     <underline>
      <bold>Properties</bold>
     </underline>
    </td>
    <td align="center">Darunavir </td>
    <td align="center">Dexamethasone </td>
    <td align="center">Enalapril </td>
    <td align="center">Favipiravir </td>
    <td align="center">Losartan </td>
    <td align="center">Nelfinavir </td>
    <td align="center">Olmesartan </td>
    <td align="center">Remdesivir </td>
   </tr>
   <tr>
    <td rowspan="2">PPB (Plasma Protein Binding) : 90% </td>
    <td align="center">Optimal </td>
    <td align="center">Less </td>
    <td align="center">Less </td>
    <td align="center">Very Less </td>
    <td align="center">Optimal </td>
    <td align="center">Optimal </td>
    <td align="center">Optimal </td>
    <td align="center">Little less </td>
   </tr>
   <tr>
    <td align="center">(93.448 %) </td>
    <td align="center">(67.738 %) </td>
    <td align="center">(76.383 %) </td>
    <td align="center">(20.55 %) </td>
    <td align="center">(90.596 %) </td>
    <td align="center">(94.791 % </td>
    <td align="center">(91.5 %) </td>
    <td align="center">(89.386 %) </td>
   </tr>
   <tr>
    <td rowspan="2">Blood-Brain Barrier (BBB)BB ratio &gt; =0.1: BBB+; BB ratio &lt;0.1: BBB– </td>
    <td align="center">–––</td>
    <td align="center">+++</td>
    <td align="center">–––</td>
    <td align="center">+++</td>
    <td align="center">–––</td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">–––</td>
   </tr>
   <tr>
    <td align="center">(0.187) </td>
    <td align="center">(0.989) </td>
    <td align="center">(0.043) </td>
    <td align="center">(0.996) </td>
    <td align="center">(0.059) </td>
    <td align="center">(0.043) </td>
    <td align="center">(0.034) </td>
    <td align="center">(0.175) </td>
   </tr>
   <tr>
    <td align="left">VD (Volume Distribution) 0.04 ∼ 20 L/kg </td>
    <td align="center">–1.228 L/kg </td>
    <td align="center">–0.036 L/kg </td>
    <td align="center">–0.278 L/kg </td>
    <td align="center">–0.686 L/kg </td>
    <td align="center">–0.111 L/kg </td>
    <td align="center">0.234 L/kg </td>
    <td align="center">–0.823 L/kg </td>
    <td align="center">–1.167 L/kg </td>
   </tr>
   <tr>
    <td colspan="9">
     <underline>
      <bold>Metabolism</bold>
     </underline>
    </td>
   </tr>
   <tr>
    <td align="left">
     <underline>
      <bold>Properties</bold>
     </underline>
    </td>
    <td align="center">Darunavir </td>
    <td align="center">Dexamethasone </td>
    <td align="center">Enalapril </td>
    <td align="center">Favipiravir </td>
    <td align="center">Losartan </td>
    <td align="center">Nelfinavir </td>
    <td align="center">Olmesartan </td>
    <td align="center">Remdesivir </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP1A2 inhibitor </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">+</td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
   </tr>
   <tr>
    <td align="center">(0.041) </td>
    <td align="center">(0.023) </td>
    <td align="center">(0.034) </td>
    <td align="center">(0.075) </td>
    <td align="center">(0.6) </td>
    <td align="center">(0.093) </td>
    <td align="center">(0.089) </td>
    <td align="center">(0.138) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP1A2 Substrate </td>
    <td align="center">– </td>
    <td align="center">– </td>
    <td align="center">– </td>
    <td align="center">+</td>
    <td align="center">+</td>
    <td align="center">– </td>
    <td align="center">– </td>
    <td align="center">– </td>
   </tr>
   <tr>
    <td align="center">(0.452) </td>
    <td align="center">(0.413) </td>
    <td align="center">(0.378) </td>
    <td align="center">(0.52) </td>
    <td align="center">(0.516) </td>
    <td align="center">(0.444) </td>
    <td align="center">(0.44) </td>
    <td align="center">(0.304) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP3A4 inhibitor </td>
    <td align="center">++</td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">+</td>
    <td align="center">+++</td>
    <td align="center">+</td>
    <td align="center">+</td>
   </tr>
   <tr>
    <td align="center">(0.723) </td>
    <td align="center">(0.246) </td>
    <td align="center">(0.069) </td>
    <td align="center">(0.021) </td>
    <td align="center">(0.636) </td>
    <td align="center">(0.907) </td>
    <td align="center">(0.565) </td>
    <td align="center">(0.693) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP3A4 substrate </td>
    <td align="center">+++</td>
    <td align="center">+++</td>
    <td align="center">++</td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">++</td>
    <td align="center">+</td>
    <td align="center">– </td>
   </tr>
   <tr>
    <td align="center">(0.916) </td>
    <td align="center">(0.946) </td>
    <td align="center">(0.817) </td>
    <td align="center">(0.264) </td>
    <td align="center">(0.836) </td>
    <td align="center">(0.89) </td>
    <td align="center">(0.592) </td>
    <td align="center">(0.454) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP2C9 inhibitor </td>
    <td align="center">+</td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">+</td>
    <td align="center">+</td>
    <td align="center">+</td>
   </tr>
   <tr>
    <td align="center">(0.566) </td>
    <td align="center">(0.024) </td>
    <td align="center">(0.048) </td>
    <td align="center">(0.017) </td>
    <td align="center">(0.752) </td>
    <td align="center">(0.571) </td>
    <td align="center">(0.634) </td>
    <td align="center">(0.568) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP2C9 substrate </td>
    <td align="center">++</td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">++</td>
    <td align="center">+</td>
    <td align="center">– </td>
   </tr>
   <tr>
    <td align="center">(0.703) </td>
    <td align="center">(0.022) </td>
    <td align="center">(0.078) </td>
    <td align="center">(0.292) </td>
    <td align="center">(0.791) </td>
    <td align="center">(0.748) </td>
    <td align="center">(0.605) </td>
    <td align="center">(0.332) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP2C19 inhibitor </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">– </td>
    <td align="center">– </td>
    <td align="center">– </td>
   </tr>
   <tr>
    <td align="center">(0.136) </td>
    <td align="center">(0.089) </td>
    <td align="center">(0.109) </td>
    <td align="center">(0.066) </td>
    <td align="center">(0.842)</td>
    <td align="center">(0.382) </td>
    <td align="center">(0.473) </td>
    <td align="center">(0.472) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP2C19 substrate </td>
    <td align="center">– </td>
    <td align="center">– </td>
    <td align="center">– </td>
    <td align="center">––– </td>
    <td align="center">– </td>
    <td align="center">++</td>
    <td align="center">– </td>
    <td align="center">––– </td>
   </tr>
   <tr>
    <td align="center">(0.408) </td>
    <td align="center">(0.41) </td>
    <td align="center">(0.407) </td>
    <td align="center">(0.216) </td>
    <td align="center">(0.492) </td>
    <td align="center">(0.766) </td>
    <td align="center">(0.346) </td>
    <td align="center">(0.238) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP2D6 inhibitor </td>
    <td align="center">– </td>
    <td align="center">+</td>
    <td align="center">– </td>
    <td align="center">––– </td>
    <td align="center">+</td>
    <td align="center">– </td>
    <td align="center">– </td>
    <td align="center">– </td>
   </tr>
   <tr>
    <td align="center">(0.496) </td>
    <td align="center">(0.523) </td>
    <td align="center">(0.337) </td>
    <td align="center">(0.172) </td>
    <td align="center">(0.562) </td>
    <td align="center">(0.456) </td>
    <td align="center">(0.461) </td>
    <td align="center">(0.385) </td>
   </tr>
   <tr>
    <td rowspan="2">P450 CYP2D6 substrate </td>
    <td align="center">+</td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">––– </td>
    <td align="center">– </td>
   </tr>
   <tr>
    <td align="center">(0.636) </td>
    <td align="center">(0.009) </td>
    <td align="center">(0.202) </td>
    <td align="center">(0.218) </td>
    <td align="center">(0.195) </td>
    <td align="center">(0.836) </td>
    <td align="center">(0.223) </td>
    <td align="center">(0.331 </td>
   </tr>
   <tr>
    <td colspan="9">
     <underline>
      <bold>Excretion</bold>
     </underline>
    </td>
   </tr>
   <tr>
    <td align="left">
     <underline>
      <bold>Properties</bold>
     </underline>
    </td>
    <td align="center">Darunavir </td>
    <td align="center">Dexamethasone </td>
    <td align="center">Enalapril </td>
    <td align="center">Favipiravir </td>
    <td align="center">Losartan </td>
    <td align="center">Nelfinavir </td>
    <td align="center">Olmesartan </td>
    <td align="center">Remdesivir </td>
   </tr>
   <tr>
    <td rowspan="3">T 1/2 (Half-Life Time; Range: &gt;8 h: high; 3 h &lt; Cl &lt; 8 h: moderate; &lt;3 h: low) </td>
    <td align="center">Low </td>
    <td align="center">Low </td>
    <td align="center">Low </td>
    <td align="center">Low </td>
    <td align="center">Low </td>
    <td align="center">Low </td>
    <td align="center">Low </td>
    <td align="center">Low </td>
   </tr>
   <tr>
    <td align="center">(1.32 h) </td>
    <td align="center"> (1.27 h) </td>
    <td align="center"> (0.95 h) </td>
    <td align="center"> (0.69 h) </td>
    <td align="center"> (2.01 h) </td>
    <td align="center"> (1.58 h) </td>
    <td align="center"> (1.74 h) </td>
    <td align="center"> (1.42 h) </td>
   </tr>
   <tr>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td colspan="9">Toxicity</td>
   </tr>
   <tr>
    <td align="left">Properties </td>
    <td align="center">Darunavir </td>
    <td align="center">Dexamethasone </td>
    <td align="center">Enalapril </td>
    <td align="center">Favipiravir </td>
    <td align="center">Losartan </td>
    <td align="center">Nelfinavir </td>
    <td align="center">Olmesartan </td>
    <td align="center">Remdesivir </td>
   </tr>
   <tr>
    <td rowspan="2">hERG (hERG Blockers) </td>
    <td align="center">++</td>
    <td align="center">++</td>
    <td align="center">– </td>
    <td align="center">––– </td>
    <td align="center">++</td>
    <td align="center">++</td>
    <td align="center">++</td>
    <td align="center">+</td>
   </tr>
   <tr>
    <td align="center">(0.7) </td>
    <td align="center">(0.7) </td>
    <td align="center">(0.427) </td>
    <td align="center">(0.171) </td>
    <td align="center">(0.874) </td>
    <td align="center">(0.764) </td>
    <td align="center">(0.743) </td>
    <td align="center">(0.65) </td>
   </tr>
   <tr>
    <td rowspan="2">AMES (Ames Mutagenicity) </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">––– </td>
    <td align="center">+</td>
    <td align="center">––– </td>
    <td align="center">– </td>
    <td align="center">––– </td>
   </tr>
   <tr>
    <td align="center">(0.13) </td>
    <td align="center">(0.13) </td>
    <td align="center">(0.11) </td>
    <td align="center">(0.232) </td>
    <td align="center">(0.552) </td>
    <td align="center">(0.194) </td>
    <td align="center">(0.362) </td>
    <td align="center">(0.276) </td>
   </tr>
   <tr>
    <td rowspan="2">DILI (Drug-Induced Liver Injury) </td>
    <td align="center">+++</td>
    <td align="center">––– </td>
    <td align="center">– </td>
    <td align="center">++</td>
    <td align="center">++</td>
    <td align="center">+</td>
    <td align="center">++</td>
    <td align="center">++</td>
   </tr>
   <tr>
    <td align="center">(0.936) </td>
    <td align="center">(0.004) </td>
    <td align="center">(0.35) </td>
    <td align="center">(0.786) </td>
    <td align="center">(0.886) </td>
    <td align="center">(0.694) </td>
    <td align="center">(0.774) </td>
    <td align="center">(0.772) </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
